[PDF][PDF] Absorbed radiation dose to humans from technetium-99m-teboroxime

RK Narra, T Feld, AD Nunn - Journal of Nuclear Medicine, 1992 - Soc Nuclear Med
Tissue distribution data obtained in nine normal volunteers were used to estimate the
radiation dose to humans after intravenous administration of 99nq'c-teboroxime (Cardiotec) …

Tc-99m HIDA dosimetry in patients with various hepatic disorders.

RK Wu, JA Siegel, Z Rattner… - Journal of Nuclear …, 1984 - europepmc.org
The pharmacodynamics of Tc-99m dimethyliminodiacetic acid were studied for normal
subjects and for patients with a variety of hepatobiliary disorders. It was determined that, in …

[PDF][PDF] Radiation dose calculation for Tc-99m HIDA in health and disease

PH Brown, GT Krishnamurthy, VVR Bobba… - Journal of Nuclear …, 1981 - Soc Nuclear Med
MATERIALS AND METHODS Fifteen healthy adult volunteers for normal controls (NC), and
25 patients with liver disease, were studied. The patients were divided into four groups …

[PDF][PDF] Evaluation of the renal clearance of technetium-99m PAHIDA in dogs

DA Summerville, AB Packard, B Bartynski… - Journal of nuclear …, 1987 - Soc Nuclear Med
MATERIALS AND METhODS Technetium-99m PAHIDA was prepared as previously de
scribed (5). OIH was purified by HPLC using a C-l8 reverse phase column (4.5 x 250 mm) …

[PDF][PDF] 99mTc-technetium dioxide for liver scanning

AE Johnson, F Gollan - Journal of Nuclear Medicine, 1970 - Soc Nuclear Med
METHODS AND RESULTS One milliliter of 0.5 N hydrochloric acid and 1 ml of 0.5 N sodium
borohydride are added to a sterile rubber-stoppered injection vial containing 25 ml sterile …

Technetium 99m as a scanning agent

PV Harper, KA Lathrop, F Jiminez, R Fink, A Gottschalk - Radiology, 1965 - pubs.rsna.org
INTEREST has increased over the past few years in the use of technetium 99m as a
radioactive tracer material for organ and tumor localization studies (1). Initially, attention was …

Internal dosimetry of technetium-99m-labelled radiopharmaceuticals used in clinical nuclear medicine

HD Roedler - Ann. Assoc. Belge Radioprot.;(Belgium), 1977 - osti.gov
For radiopharmaceuticals labelled with/sup 99m/Tc, which is the most common short-lived
radionuclide used in nuclear medicine, the possible dose reduction in comparison to other …

In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.

JC Maublant, Z Zhang, M Rapp, M Ollier… - Journal of nuclear …, 1993 - europepmc.org
Since 201Tl, 99mTc-sestamibi and 99mTc-teboroxime concentrate in cardiac cells through
different mechanisms, we compared their uptake in cultured normal cells and carcinoma cell …

[PDF][PDF] Dosimetry of four heart-imaging radionuclides: 43K, 81Rb, 129Cs, and 201Tl

PA Feller, VJ Sodd - Journal of Nuclear Medicine, 1975 - Soc Nuclear Med
RESULTS The estimates of absorbed radiation dose to the whole body and to five organs,
from 1 mCi of each of the four nuclides administered intravenously, are listed in Table 2 …

Urinary Excretion and External Radiation Dose from Patients Administered Tallium-201 and Technetium-99m Methoxy Isobutyl Isonitrile

A Sattari, S Dadashzadeh… - Radiation protection …, 2001 - academic.oup.com
In this study, the dose rates at various distances of 5, 10, 50 and 100 cm from 70 patients,
who were administered diagnostic amounts of 201Tl-chloride and 99Tcm-MIBI, was …